Gokcen Omeroglu Simsek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gokcen Omeroglu Simsek has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Özgür Appak
Dokuz Eylül Üniversitesi
4 shared publications - Arzu Nazlı
Dokuz Eylül University Faculty of Medicine, Department of Infectious Diseases, İzmir, Türkiye
3 shared publications - Oya Özlem Eren Kutsoylu
Dokuz Eylül Üniversitesi
3 shared publications - Ahmet Naci Emecen
Department of Public Health, Epidemiology Subsection, Faculty of Medicine, Dokuz Eylül University, Balçova, Izmir, Turkey
2 shared publications - Aylin Ozgen Alpaydin
Dokuz Eylul University
2 shared publications - Ayça Arzu Sayıner
Department of Medical Microbiology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey
2 shared publications
Latest Publications
- Open Access
- 18 September 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 24 (6) , 284-291
Vaccination Status and Outcome of Hospitalized Patients with Coronavirus Disease 2019 Before and After the Spread of Omicron Variant: An Observational Study from İzmir, Turkey
COVID-19,omicron,vaccination,breakthrough infection,hospitalization
- 18 September 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 24 (6) , 284-291
Open AccessVaccination Status and Outcome of Hospitalized Patients with Coronavirus Disease 2019 Before and After the Spread of Omicron Variant: An Observational Study from İzmir, Turkey
COVID-19,omicron,vaccination,breakthrough infection,hospitalization
- Open Access
- 30 March 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 24 (2) , 91-95
Can Some Viral Respiratory Infections Observed Before the Pandemic Announcement Be Related to SARS-CoV-2?
2019 novel coronavirus disease,polymerase chain reaction,non-severe acute respiratory syndrome,pandemic,severe acute respiratory syndrome coronavirus 2
- 30 March 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 24 (2) , 91-95
Open AccessCan Some Viral Respiratory Infections Observed Before the Pandemic Announcement Be Related to SARS-CoV-2?
2019 novel coronavirus disease,polymerase chain reaction,non-severe acute respiratory syndrome,pandemic,severe acute respiratory syndrome coronavirus 2
- 12 July 2022
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 192 (1) , 263-268
Evaluation of SARS-CoV-2 antibody persistence and viral spread in stool: a long-term care experience before COVID-19 vaccination
Background Due to elderly residents, nursing homes/assisted living facilities were the most affected places in COVID-19 pandemic. Besides symptomatic patients, asymptomatic patients were detected during routine screening. Aim This study aims to determine the factors that affect antibody response and viral shedding in stool samples after natural exposure to the virus in residents and staff who recovered from COVID-19 before the vaccine was available. Methods This prospective cross-sectional study was conducted at the nation’s highest-capacity Residential and Nursing Home. Blood samples were collected between December 15, 2020 and January 15, 2021 from participating residents and staff for anti-SARS-CoV-2 antibody testing. Stool samples were obtained for SARS-CoV-2 PCR testing 2 months after COVID-19. The Social Sciences (SPSS) program version 15.0 was used for statistical analysis. The Mann–Whitney U test compared SARS‐CoV‐2 antibody concentration between two groups. Results Four hundred sixty-four (52.3%) residents and 424 (47.7%) staff participated. Entirely 259 (29.2%) participants were anti-SARS-CoV-2 IgG (+) and 255 (28.7%) were SARS-CoV-2 PCR (+). Both antibody and PCR positivity was detected in 196 (76.9%). In PCR (−) group, 63 (10.0%) participants were SARS-CoV‐2 IgG (+). Antibody titers were found highest in SARS-CoV-2 PCR (+) male residents. SARS-CoV-2 IgG titers were significantly high in SARS-CoV-2 PCR (+) and hospitalized participants regardless of age. Stool samples were obtained from 61(23.9%) participants and were found negative. Conclusion A durable SARS-CoV‐2 IgG antibody response was monitored at least 9 months after the participants were diagnosed with COVID-19. SARS-CoV-2 antibody positivity was detected 76.9% in PCR (+) and 10.0% in PCR (−) participants. Knowing the duration of detectable antibodies is an important finding for developing disease prevention and public health strategies.
- 12 July 2022
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 192 (1) , 263-268
Evaluation of SARS-CoV-2 antibody persistence and viral spread in stool: a long-term care experience before COVID-19 vaccination
Background Due to elderly residents, nursing homes/assisted living facilities were the most affected places in COVID-19 pandemic. Besides symptomatic patients, asymptomatic patients were detected during routine screening. Aim This study aims to determine the factors that affect antibody response and viral shedding in stool samples after natural exposure to the virus in residents and staff who recovered from COVID-19 before the vaccine was available. Methods This prospective cross-sectional study was conducted at the nation’s highest-capacity Residential and Nursing Home. Blood samples were collected between December 15, 2020 and January 15, 2021 from participating residents and staff for anti-SARS-CoV-2 antibody testing. Stool samples were obtained for SARS-CoV-2 PCR testing 2 months after COVID-19. The Social Sciences (SPSS) program version 15.0 was used for statistical analysis. The Mann–Whitney U test compared SARS‐CoV‐2 antibody concentration between two groups. Results Four hundred sixty-four (52.3%) residents and 424 (47.7%) staff participated. Entirely 259 (29.2%) participants were anti-SARS-CoV-2 IgG (+) and 255 (28.7%) were SARS-CoV-2 PCR (+). Both antibody and PCR positivity was detected in 196 (76.9%). In PCR (−) group, 63 (10.0%) participants were SARS-CoV‐2 IgG (+). Antibody titers were found highest in SARS-CoV-2 PCR (+) male residents. SARS-CoV-2 IgG titers were significantly high in SARS-CoV-2 PCR (+) and hospitalized participants regardless of age. Stool samples were obtained from 61(23.9%) participants and were found negative. Conclusion A durable SARS-CoV‐2 IgG antibody response was monitored at least 9 months after the participants were diagnosed with COVID-19. SARS-CoV-2 antibody positivity was detected 76.9% in PCR (+) and 10.0% in PCR (−) participants. Knowing the duration of detectable antibodies is an important finding for developing disease prevention and public health strategies.
- 14 June 2021
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 26 (2) , 267-276
Hafif Seyirli COVID-19 Hastalarının İnfeksiyondan Altı Ay Sonraki Mortalite ve Reinfeksiyon Oranları
- 14 June 2021
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 26 (2) , 267-276
Hafif Seyirli COVID-19 Hastalarının İnfeksiyondan Altı Ay Sonraki Mortalite ve Reinfeksiyon Oranları
- 30 April 2021
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 34 (1) , 61-68
Epidemiological Characteristics of COVID-19 Cases in A University Hospital in Turkey
Objective: It is important to put forward the characteristics of the COVID-19 cases to fight the disease effectively. The aim of this study is to determine the epidemiological characteristics of COVID-19 cases in Turkey. And also to determine the risk factors associated with intensive care unit (ICU) admission and death. Methods: In this cross-sectional study, the characteristics of the confirmed COVID-19 cases who applied to a University Hospital in Turkey between March 19th and June 11th, 2020, were analyzed. Variables such as epidemic trend, case fatality rate, need for hospitalization, ICU admission rate, and ICU mortality were calculated. In addition, risk factors affecting ICU admission and death were determined by logistic regression analysis. Results: 19.8% of 654 cases participating in the study were asymptomatic at admission. ICU admission rate was 7.6% and case fatality rate found to be 7.8%. Age, male gender, and cancer were associated with ICU admission. Each 1-unit increase in age increased ICU admissions by 8% (OR: 1.08; CI: 1.06-1.10). Men had a 2.71 times higher risk of ICU admission (OR: 2.71; CI: 1.37-5.39); and cancer patients showed 3.72 (OR: 3.72; CI: 1.35-10.20) times more ICU admissions (p<0.05). Age, cancer, and ICU admission were associated with death. Each 1-unit increase in age increased the risk of death by 10% (OR: 1.10; CI: 1.06-1.15). The risk of death was found to be 5.22 times higher in cancer patients (OR: 5.22; GA: 1.09-24.89) and 87.42 times higher in those admitted to ICU (OR: 87.42; GA: 30.15-153.46) (p<0.05). Conclusions: It was revealed that the course of the disease worsens, and deaths increase with age. Male gender has been associated with the increased need for intensive care. Cancer was significantly associated both with ICU admission and death. Attention should be paid to the groups of elderly, men and those with a comorbidity. More detailed studies with larger samples are of critical importance in fighting against the pandemic. Key Words: Turkey, COVID-19, coronavirus, SARS-CoV-2, epidemiology.
- 30 April 2021
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 34 (1) , 61-68
Epidemiological Characteristics of COVID-19 Cases in A University Hospital in Turkey
Objective: It is important to put forward the characteristics of the COVID-19 cases to fight the disease effectively. The aim of this study is to determine the epidemiological characteristics of COVID-19 cases in Turkey. And also to determine the risk factors associated with intensive care unit (ICU) admission and death. Methods: In this cross-sectional study, the characteristics of the confirmed COVID-19 cases who applied to a University Hospital in Turkey between March 19th and June 11th, 2020, were analyzed. Variables such as epidemic trend, case fatality rate, need for hospitalization, ICU admission rate, and ICU mortality were calculated. In addition, risk factors affecting ICU admission and death were determined by logistic regression analysis. Results: 19.8% of 654 cases participating in the study were asymptomatic at admission. ICU admission rate was 7.6% and case fatality rate found to be 7.8%. Age, male gender, and cancer were associated with ICU admission. Each 1-unit increase in age increased ICU admissions by 8% (OR: 1.08; CI: 1.06-1.10). Men had a 2.71 times higher risk of ICU admission (OR: 2.71; CI: 1.37-5.39); and cancer patients showed 3.72 (OR: 3.72; CI: 1.35-10.20) times more ICU admissions (p<0.05). Age, cancer, and ICU admission were associated with death. Each 1-unit increase in age increased the risk of death by 10% (OR: 1.10; CI: 1.06-1.15). The risk of death was found to be 5.22 times higher in cancer patients (OR: 5.22; GA: 1.09-24.89) and 87.42 times higher in those admitted to ICU (OR: 87.42; GA: 30.15-153.46) (p<0.05). Conclusions: It was revealed that the course of the disease worsens, and deaths increase with age. Male gender has been associated with the increased need for intensive care. Cancer was significantly associated both with ICU admission and death. Attention should be paid to the groups of elderly, men and those with a comorbidity. More detailed studies with larger samples are of critical importance in fighting against the pandemic. Key Words: Turkey, COVID-19, coronavirus, SARS-CoV-2, epidemiology.